Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of
1995. All statements contained in this press release that do not relate to matters of historical fact should be considered
forward-looking statements, including without limitation statements regarding our future results of operations and financial
position, industry and business trends, including the anticipated impact of retail pharmacy closures, our value proposition,
consumer and partner perception and our position in the healthcare ecosystem/industry, our integrated savings programs,
our business strategy and our ability to execute on our strategic priorities and value creation, our plans, market opportunity
and long-term growth prospects, our capital allocation priorities, our executive officer transitions; our ability to expand our
offerings through partnerships with pharmaceutical companies; the impacts of PBM regulation and reform on our business;
the anticipated short-term growth in our prescription marketplace and pharma manufacturer solutions offerings and our
objectives for future operations. These statements are neither promises nor guarantees, but involve known and unknown
risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be
materially different from any future results, performance or achievements expressed or implied by the forward-looking
statements, including, but not limited to, risks related to our limited operating history and early stage of growth; our recent
growth rates may not be sustainable or indicative of future growth; our ability to achieve broad market education and change
consumer purchasing habits; our general ability to continue to attract, acquire and retain consumers in a cost-effective
manner; our significant reliance on our prescription transactions offering and ability to expand our offerings; changes in
medication pricing and the significant impact of pricing structures negotiated by industry participants; our general inability to
control the categories and types of prescriptions for which we can offer savings or discounted prices; our reliance on a
limited number of industry participants, including pharmacy benefit managers, pharmacies, and pharma manufacturers; the
competitive nature of industry; risks related to pandemics, epidemics or outbreak of infectious disease; the accuracy of our
estimate of our addressable market and other operational metrics; our ability to respond to changes in the market for
prescription pricing and to maintain and expand the use of GoodRx codes; our ability to maintain positive perception of our
platform or maintain and enhance our brand; risks related to any failure to maintain effective internal control over financial
reporting; risks related to use of social media, emails, text messages and other messaging channels as part of our marketing
strategy; our dependence on our information technology systems and those of our third-party vendors, and risks related to
any failure or significant disruptions thereof; risks related to government regulation of the internet, e-commerce, consumer
data and privacy, information technology and cybersecurity; risks related to the use of AI and machine learning in our
business; risks related to a decrease in consumer willingness to receive correspondence or any technical, legal or any other
restrictions to send such correspondence; risks related to any failure to comply with applicable data protection, privacy and
security, advertising and consumer protection laws, regulations, standards, and other requirements; our ability to utilize our
net operating loss carryforwards and certain other tax attributes; the risk that we may be unable to realize expected benefits
from our restructuring and cost reduction efforts; our ability to attract, develop, motivate and retain well-qualified employees;
risks related to our acquisition strategy; risks related to our debt arrangements; interruptions or delays in service on our apps
or websites or any undetected errors or design faults; our reliance on third-party platforms to distribute our platform and
offerings, including software as-a-service technologies; systems failures or other disruptions in the operations of these
parties on which we depend; risks related to climate change; the increasing focus on environmental sustainability and social
initiatives; risks related to our intellectual property; risks related to operating in the healthcare industry; risks related to our
organizational structure; litigation related risks; our ability to accurately forecast revenue and appropriately plan our
expenses in the future; risks related to general economic factors, natural disasters or other unexpected events; risks related
to fluctuations in our tax obligations and effective income tax rate which could materially and adversely affect our results of
operations; risks related to the healthcare reform legislation and other proposed or future changes impacting the healthcare
industry and healthcare spending which may adversely affect our business, financial condition and results of operations; as
well as the other important factors discussed in the section entitled “Risk Factors” of our Annual Report on Form 10-K for the
fiscal year ended December 31, 2024 and in our other filings with the Securities and Exchange Commission. The forward-
looking statements in this press release are based upon information available to us as of the date of this press release, and
while we believe such information forms a reasonable basis for such statements, such information may be limited or
incomplete, and our statements should not be read to indicate that we have conducted an exhaustive inquiry into, or review
of, all potentially available relevant information. These statements are inherently uncertain and investors are cautioned not to
unduly rely upon these statements. While we may elect to update such forward-looking statements at some point in the
future, we disclaim any obligation to do so, even if subsequent events cause our views to change.
